Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype

Cytokine

Volumn 73, Issue 1, 2015, Pages 8-15

  Nakamura, Kiwamu ^a   Ito, Ichiaki ^a   Kobayashi, Makiko ^a,b   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

CCL1; Monocytes; Orosomucoid

Indexed keywords

BACITRACIN; CCL1 CHEMOKINE; CD163 ANTIGEN; CD209 ANTIGEN; CD64 ANTIGEN; CXCL13 CHEMOKINE; DRINKING WATER; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 4; LANSOPRAZOLE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M2C RECEPTOR; MUSCARINIC M3 RECEPTOR; OROSOMUCOID; OROSOMUCOID 1; PENICILLIN DERIVATIVE; STREPTOMYCIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; UNCLASSIFIED DRUG; CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; IMMUNOPATHOGENESIS; INOCULATION; LEUKOCYTE; MALE; MEMBRANE RECONSTITUTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MONOCYTE; MOUSE; MOUTH INFECTION; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; POLARIZATION; WASTE MANAGEMENT; ANIMAL; BIOSYNTHESIS; CELL POLARITY; DRUG EFFECTS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; PATHOLOGY;

ENTEROCOCCUS FAECALIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS;

ANIMALS; CELL POLARITY; CELLS, CULTURED; CHEMOKINES; ENTEROCOCCUS FAECALIS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MONOCYTES; OPPORTUNISTIC INFECTIONS; OROSOMUCOID; PHENOTYPE;

EID: 84922747187     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.01.017     Document Type: Article

References (58)

1. Schmid K., Kaufmann H., Isemura S., Bauer F., Emura J., Motoyama T., et al. Structure of alpha-1-acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins. Biochemistry 1973, 12:2711-2724.
2. Kishino S., Nomura A., Itoh S., Nakagawa T., Takekuma Y., Sugawara M., et al. Age- and gender-related differences in carbohydrate concentrations of α1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities. Eur J Clin Pharmacol 2002, 58:621-628.
3. Ceciliani F., Pocacqua V. The acute phase protein α1-acid glycoprotein: a model for altered glycosylation during diseases. Curr Protein Pept Sci 2007, 8:91-108.
4. Duché J.C., Urien S., Simon N., Malaurie E., Monnet I., Barré J. Expression of the genetic variants of human alpha-1-acid glycoprotein in cancer. Clin Biochem 2000, 33:197-202.
5. Budai L., Ozohanics O., Ludányi K., Drahos L., Kremmer T., Krenyacz J., et al. Investigation of genetic variants of alpha-1 acid glycoprotein by ultra-performance liquid chromatography-mass spectrometry. Anal Bioanal Chem 2009, 393:991-998.
6. Hanada K., Yamanaka E., Yamamoto N., Minami H., Kawai S., Sasaki Y., et al. Effects of surgery and chronic disease states on the concentrations and phenotype distribution of α1-acid glycoprotein: studies in patients with breast cancer and patients with chronic inflammatory disease. Int J Clin Pharmacol Ther 2011, 49:415-421.
7. Kundin W.D., Mechali P., Hollinshead A.C., Bensimon H., Miller H. Cancer serum index: a useful nonspecific test as a parameter in multimodality screening and assessment of patients with cancer of the prostate. Prostate 1981, 2:207-217.
8. Ongay S., Martín-Álvarez P.J., Neusüss C., de Frutos M. Statistical evaluation of CZE-UV and CZE-ESI-MS data of intact α-1-acid glycoprotein isoforms for their use as potential biomarkers in bladder cancer. Electrophoresis 2010, 31:3314-3325.
9. Bloedow D.C., Hansbrough J.F., Hardin T., Simons M. Postburn serum drug binding and serum protein concentrations. J Clin Pharmacol 1986, 26:147-151.
10. Bonate P.L. Pathophysiology and pharmacokinetics following burn injury. Clin Pharmacokinet 1990, 18:118-130.
11. Melezyńska-Matej M., Koziell J., Tolkacz M., Czernik J., Grzybek-Hryncewicz K. The dependence of serum opsonic activity on fibronectin and alpha-1 acid glycoprotein levels in children with burns. Pediatr Pol 1996, 71:511-516.
12. Wu X., Thomas S.J., Herndon D.N., Sanford A.P., Wolf S.E. Insulin decreases hepatic acute phase protein levels in severely burned children. Surgery 2004, 135:196-202.
13. Xia Z.F., Coolbaugh M.I., He F., Herndon D.N., Papaconstantinou J. The effects of burn injury on the acute phase response. J Trauma 1992, 32:245-250.
14. Vostrugina K., Gudaviciene D., Vitkauskiene A. Bacteremias in patients with severe burn trauma. Medicina 2006, 42:576-579.
15. Sharma B.R. Infection in patients with severe burns: causes and prevention thereof. Infect Dis Clin North Am 2007, 21:745-759.
16. Kosmidis C.I., Chandrasekar P.H. Management of gram-positive bacterial infections in patients with cancer. Leuk Lymphoma 2012, 53:8-18.
17. Shibata Y., Tamura K., Ishida N. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res 1983, 43:2889-2896.
18. Bories P.N., Guenounou M., Féger J., Kodari E., Agneray J., Durand G. Human alpha 1-acid glycoprotein-exposed macrophages release interleukin 1 inhibitory activity. Biochem Biophys Res Commun 1987, 147:710-715.
19. Majima T., Otsuji K., Nagatomi R., Konno T. Polysaccharide (ANK-102) from Polianthes tuberosa cells deteriorates the resistance of mice to Listeria monocytogenes infection. Immunopharmacol Immunotoxicol 1995, 17:59-68.
20. Fu Y.X., Watson G.A., Kasahara M., Lopez D.M. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF. J Immunol 1991, 146:783-789.
21. 1-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress. J Biol Chem 2012, 287:30688-30700.
22. 1-Acid glycoprotein (AGP) stimulates resident macrophages to generate alternatively activated macrophages (AAMϕ). Part I. Biological properties of AGP-induced AAMϕ. FASEB J 2003, 17:C160.
23. Takano S., Sami S., Majima T., Ishida N. Low molecular weight immunosuppressive factors found in elevated amounts in cancer ascitic fluids of mice. 2. 1-Methyladenosine isolated from cancer ascitic fluids enhances Listeria infection in mice. J Immunopharmacol 1986, 8:59-73.
24. Silva M.T. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 2010, 87:93-106.
25. Mowat A.M., Bain C.C. Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun 2011, 3:550-564.
26. Rosenberger C.M., Finlay B.B. Phagocyte sabotage: disruption of macrophage signaling by bacterial pathogens. Nat Rev Mol Cell Biol 2003, 4:385-396.
27. Tanaka H., Miyazaki S., Sumiyama Y., Kakiuchi T. Role of macrophages in a mouse model of postoperative MRSA enteritis. J Surg Res 2004, 118:114-121.
28. Katakura T., Yoshida T., Kobayashi M., Herndon D.N., Suzuki F. Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries. Clin Exp Immunol 2005, 142:419-425.
29. Stout R.D., Watkins S.K., Suttles J. Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J Leukoc Biol 2009, 86:1105-1109.
30. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012, 122:787-795.
31. Edwards J.P., Zhang X., Frauwirth K.F., Mosser D.M. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006, 80:1298-1307.
32. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
33. Kobayashi M., Jeschke M.G., Shigematsu K., Asai A., Yoshida S., Herndon D.N., et al. M2b monocytes predominated in peripheral blood of severely burned patients. J Immunol 2010, 185:7174-7179.
34. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002, 23:549-555.
35. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
36. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front Biosci 2008, 13:453-461.
37. Tang X., Mo C., Wang Y., Wei D., Xiao H. Anti-tumour strategies aiming to target tumor-associated macrophages. Immunology 2013, 138:93-104.
38. Katakura T., Miyazaki M., Kobayashi M., Herndon D.N., Suzuki F. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 2004, 172:1407-1413.
39. Shigematsu K., Asai A., Kobayashi M., Herndon D.N., Suzuki F. Enterococcus faecalis translocation in mice with severe burn injury: a pathogenic role of CCL2 and alternatively activated macrophages (M2aMϕ and M2cMϕ). J Leukoc Biol 2009, 86:999-1005.
40. Asai A., Nakamura K., Kobayashi M., Herndon D.N., Suzuki F. CCL1 released from M2b macrophages is essentially required for the maintenance of their properties. J Leukoc Biol 2012, 92:859-867.
41. Sironi M., Martinez F.O., D'Ambrosio D., Gattorno M., Polentarutti N., Locati M., et al. Differential regulation of chemokine production by Fcγ receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, Type 2). J Leukoc Biol 2006, 80:342-349.
42. Durafourt B.A., Moore C.S., Zammit D.A., Johnson T.A., Zaguia F., Guiot M.C., et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 2012, 60:717-727.
43. Zizzo G., Hilliard B.A., Monestier M., Cohen P.L. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 2012, 189:3508-3520.
44. Mellins E.D., Macaubas C., Grom A.A. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat Rev Rheumatol 2011, 7:416-426.
45. Lolmede K., Campana L., Vezzoli M., Bosurgi L., Tonlorenzi R., Clementi E., et al. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol 2009, 85:779-787.
46. Piganelli J.D., Martin T., Haskins K. Splenic macrophages from the NOD mouse are defective in the ability to present antigen. Diabetes 1998, 47:1212-1218.
47. O'Brien B.A., Huang Y., Geng X., Dutz J.P., Finegood D.T. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 2002, 51:2481-2488.
48. Marée A.F., Komba M., Finegood D.T., Edelstein-Keshet L. A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice. J Appl Physiol 2008, 104:157-169.
49. Takenaka K., Prasolava T.K., Wang J.C., Mortin-Toth S.M., Khalouei S., Gan O.I., et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007, 8:1313-1323.
50. Ito M., Hiramatsu H., Kobayashi K., Suzue K., Kawahata M., Hioki K., et al. NOD/SCID/Rγnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002, 100:3175-3182.
51. Ohsugi T., Kiuchi Y., Shimoda K., Oguri S., Maejima K. Translocation of bacteria from the gastrointestinal tract in immunodeficient mice. Lab Anim 1996, 30:46-50.
52. Tsuda Y., Shigematsu K., Kobayashi M., Herndon D.N., Suzuki F. Role of polymorphonuclear neutrophils on infectious complications stemming from Enterococcus faecalis oral infection in thermally injured mice. J Immunol 2008, 180:4133-4138.
53. Zhu H., Hart C.A., Sales D., Roberts N.B. Bacterial killing in gastric juice - effect of pH and pepsin on Escherichia coli and Helicobacter pylori. J Med Microbiol 2006, 55:1265-1270.
54. Bavishi C., Dupont H.L. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011, 34:1269-1281.
55. Wong K.L., Yeap W.H., Tai J.J., Ong S.M., Dang T.M., Wong S.C. The three human monocyte subsets: implications for health and disease. Immunol Res 2012, 53:41-57.
56. 137Cs γ-irradiation. J Immunol 2012, 189:296-303.
57. Atemezem A., Mbemba E., Vassy R., Slimani H., Saffar L., Gattegno L. Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages. Biochem J 2001, 356:121-128.
58. + in neutrophil granulocytes via sialic acid binding immunoglobulin-like lectins (siglecs). FASEB J 2007, 21:4059-4069.